Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Rhythm Pharmaceuticals is a US-based biopharmaceutical company focused on developing and commercializing medicines for rare genetic diseases of obesity. The company is committed to advancing innovative therapies designed to improve the quality of life for patients worldwide affected by these conditions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Rhythm Pharmaceuticals is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Rhythm Pharmaceuticals last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.73 USD.
Across its last 3 earnings reports, Rhythm Pharmaceuticals stock moved by ±5.5% on average the following day. The largest reaction was +7.9% on 05/05/2026; 1 of 3 reactions were positive.
Rhythm Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.